Document is current

Documents that mention this clinical trial

Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research
https://doi.org/10.1136/svn-2021-001134

Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial
https://doi.org/10.1136/svn-2023-002820

Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial
https://doi.org/10.1136/svn-2023-002310

Evaluating the concordance between International Classification of Diseases, Tenth Revision Code and stroke severity as measured by the National Institutes of Health Stroke Scale
https://doi.org/10.1136/bmjno-2024-000831

European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion
https://doi.org/10.1136/neurintsurg-2021-018589

Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials
https://doi.org/10.1136/svn-2023-002396

Strategy for reliable identification of ischaemic stroke, thrombolytics and thrombectomy in large administrative databases
https://doi.org/10.1136/svn-2020-000533

Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trial
https://doi.org/10.1136/bmj-2025-085810

Tenecteplase versus standard care in patients with acute basilar artery occlusion: a multi-centre, prospective, randomised, open-label, blinded endpoint, phase 3, controlled trial
https://doi.org/10.1136/svn-2025-004432

Documents that mention this clinical trial

Characterization of length of stay after minimally invasive endoscopic intracerebral hemorrhage evacuation
https://doi.org/10.1136/jnis-2023-020152

Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research
https://doi.org/10.1136/svn-2021-001134

Early minimally invasive intracerebral hemorrhage evacuation: a phase 2a feasibility, safety, and promise of surgical efficacy study
https://doi.org/10.1136/jnis-2023-020446

Evaluating the concordance between International Classification of Diseases, Tenth Revision Code and stroke severity as measured by the National Institutes of Health Stroke Scale
https://doi.org/10.1136/bmjno-2024-000831

Minimally invasive endoscopic hematoma evacuation vs best medical management for spontaneous basal-ganglia intracerebral hemorrhage
https://doi.org/10.1136/neurintsurg-2018-014447

Strategy for reliable identification of ischaemic stroke, thrombolytics and thrombectomy in large administrative databases
https://doi.org/10.1136/svn-2020-000533

Acute intracerebral haemorrhage: diagnosis and management
https://doi.org/10.1136/practneurol-2020-002763

Early and effective intracerebral hemorrhage evacuation is associated with a lower 1-year residual cavity volume and better functional outcomes
https://doi.org/10.1136/jnis-2023-020787

Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trial
https://doi.org/10.1136/bmj-2025-085810

Tenecteplase versus standard care in patients with acute basilar artery occlusion: a multi-centre, prospective, randomised, open-label, blinded endpoint, phase 3, controlled trial
https://doi.org/10.1136/svn-2025-004432

Documents that mention this clinical trial

Lacunar stroke: mechanisms and therapeutic implications
https://doi.org/10.1136/jnnp-2021-326308

Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research
https://doi.org/10.1136/svn-2021-001134

Evaluating the concordance between International Classification of Diseases, Tenth Revision Code and stroke severity as measured by the National Institutes of Health Stroke Scale
https://doi.org/10.1136/bmjno-2024-000831

Strategy for reliable identification of ischaemic stroke, thrombolytics and thrombectomy in large administrative databases
https://doi.org/10.1136/svn-2020-000533

Documents that mention this clinical trial

Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research
https://doi.org/10.1136/svn-2021-001134

Prestroke selective serotonin reuptake inhibitor use and functional outcomes after ischaemic stroke
https://doi.org/10.1136/svn-2017-000119

Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care
https://doi.org/10.1016/j.ahj.2015.04.008

Acute management of stroke patients taking non–vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale
https://doi.org/10.1016/j.ahj.2016.07.023

Strategy for reliable identification of ischaemic stroke, thrombolytics and thrombectomy in large administrative databases
https://doi.org/10.1136/svn-2020-000533